Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.31% is 35% below its 5-year average of 2.03%, near the low end of its 5-year range (0.00%–633.06%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.51% below its 12-month average of 1.44%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.31%.
DEBT TO ASSETS RATIO
1.31%
DEBT TO ASSETS RATIO AVG TTM
1.44%
DEBT TO ASSETS RATIO AVG 3Y
2.11%
DEBT TO ASSETS RATIO AVG 5Y
2.03%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.51%
CURRENT VS 3Y AVG
-37.60%
CURRENT VS 5Y AVG
-35.25%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 671 covered companies
CURRENT VS SECTOR MEDIAN
+1213.76%
vs the sector median at left
Cognition Therapeutics, Inc.
Market Cap
$85.01M
Debt to Assets Ratio
1.31%
TTM Avg
1.44%
3Y Avg
2.11%
5Y Avg
2.03%
Market Cap
$84.78M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.74M
Debt to Assets Ratio
0.47%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.61M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$83.04M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cognition Therapeutics, Inc. (CGTX) | $85.01M | 1.31% | 1.44% | 2.11% | 2.03% |
| Nutriband Inc. (NTRB)vs › | $84.83M | 0.03% | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $85.21M | 0.48% | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $84.78M | 0.01% | N/A | N/A | N/A |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.74M | 0.47% | N/A | N/A | N/A |
| ProMIS Neurosciences, Inc. (PMN)vs › | $84.61M | 0.00% | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 0.58% | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.04M | 0.02% | N/A | N/A | N/A |
| MediciNova, Inc. (MNOV)vs › | $82.73M | 0.00% | N/A | N/A | N/A |
| LENSAR Inc (LNSR)vs › | $82.35M | 0.03% | N/A | N/A | N/A |
Debt/Assets
1.3%
Debt/Equity
0.02
Current Ratio
7.03
Interest Coverage
-3676.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.31% |
| 2026-03-31 | 1.29% |
| 2025-12-31 | 1.32% |
| 2025-09-30 | 0.88% |
| 2025-06-30 | 2.39% |
| 2025-03-31 | 2.70% |
| 2024-12-31 | 2.69% |
| 2024-09-30 | 2.10% |
| 2024-06-30 | 2.35% |
| 2024-03-31 | 2.66% |
| 2023-12-31 | 3.52% |
| 2023-09-30 | 1.90% |
| 2023-06-30 | 2.25% |
| 2023-03-31 | 2.70% |
| 2022-12-31 | 2.93% |
| 2022-09-30 | 1.34% |
| 2022-06-30 | 1.83% |
| 2022-03-31 | 2.38% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 633.06% |
| 2021-06-30 | 490.26% |
| 2021-03-31 | 76.86% |
| 2020-12-31 | 180.53% |
